Mitochondrial adenine nucleotide translocase 2 (ANT2)-mediated regulation of iron, ferroptosis, and lung repair in copd
Active Project Grant Awarded Last action
- Award ID
- F30HL184508
- Recipient
-
University Of Pittsburgh - Of The Commonwealth System Of Higher Education UEI MKAGLD59JRL1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $55,114
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 0% complete
- Place of performance
- Pittsburgh, PA 15222, USA
Award details come from USAspending.gov.
Description
- Abstract
- Chronic obstructive pulmonary disease (copd) ranks as the sixth leading cause of death in the united states. This condition is primarily marked by chronic inflammation, alveolar destruction, reduced renewal of lung epithelium, airway remodeling and thickening, and abnormalities in lung epithelial cells, with cigarette smoke identified as a significant risk factor. Current treatment options for copd are limited, and our understanding of the mechanisms underlying alveolar repair remains unclear. Recent findings suggest that mitochondrial dysfunction and impaired alveolar regeneration greatly contribute to the pathogenesis of copd. Mitochondrial dysfunction, iron dysregulation, and ferroptosis worsen lung epithelial cell injury and impede repair processes. This dysfunction disrupts energy production, increases oxidative stress, and induces iron overload, promoting alveolar cell death and reducing cell regeneration and proliferation, especially in alveolar progenitors known as alveolar type 2 (AT2) cells. However, the mechanisms that connect these processes in copd are not fully understood. We propose that adenine nucleotide translocase 2 (ANT2), a mitochondrial ADP/ATP transporter, is a critical link in these pathological processes. With single-cell RNA sequencing, ANT2 is enriched in AT2 cells but is diminished in copd patients' lungs compared to healthy individuals. We hypothesize that the loss of ANT2 in AT2 cells exacerbates metabolic changes, iron dysregulation, and ferroptotic cell death, hindering lung repair mechanisms. The goals of our proposal are to (1) examine ANT2's role in iron regulation in dysfunctional AT2 cell renewal and (2) evaluate therapeutic targeting of iron overload and ferroptosis can enhance AT2 cell repair and slow the progression of copd. We will utilize transcriptomic datasets and 3D organoid culture models, using AT2 cells from ANT2 knockout mice in relevant cigarette smoke and elastase models. This investigation will underscore the importance of mitochondrial biology in copd and lung regeneration and support my development as an independent physician-scientist focused on pulmonary mitochondrial biology through the scientific, technical, and professional skills acquired during this training.
Quick answers
Who received award F30HL184508?
F30HL184508 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Heart Lung and Blood Institute (National Institutes of Health) on February 20, 2027.
How much is award F30HL184508 worth?
$55,114 has been obligated on F30HL184508.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award